Oxidative stress in chronic vascular disease: From prediction to prevention
Tóm tắt
Từ khóa
Tài liệu tham khảo
Li, 2013, Oxidative stress in vascular disease and its pharmacological prevention, Trends Pharmacol. Sci., 34, 313, 10.1016/j.tips.2013.03.007
Rao, 2010, Isoprostane, an “intermediate phenotype” for oxidative stress heritability, risk trait associations, and the influence of chromogranin B polymorphism, J. Am. Coll. Cardiol., 56, 1338, 10.1016/j.jacc.2010.03.092
Passaglia, 2015, Angiotensin type 1 receptor mediates chronic ethanol consumption-induced hypertension and vascular oxidative stress, Vasc. Pharmacol., 10.1016/j.vph.2015.04.002
Hecker, 2009, NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury, Nat. Med., 15, 1077, 10.1038/nm.2005
Antoniades, 2007, Altered plasma versus vascular biopterins in human atherosclerosis reveal relationships between endothelial nitric oxide synthase coupling, endothelial function, and inflammation, Circulation, 116, 2851, 10.1161/CIRCULATIONAHA.107.704155
Antoniades, 2011, Rapid, direct effects of statin treatment on arterial redox state and nitric oxide bioavailability in human atherosclerosis via tetrahydrobiopterin-mediated endothelial nitric oxide synthase coupling, Circulation, 124, 10.1161/CIRCULATIONAHA.110.985150
Cunnington, 2012, Systemic and vascular oxidation limits the efficacy of oral tetrahydrobiopterin treatment in patients with coronary artery disease, Circulation, 125, 1356, 10.1161/CIRCULATIONAHA.111.038919
Shirodaria, 2007, Global improvement of vascular function and redox state with low-dose folic acid: implications for folate therapy in patients with coronary artery disease, Circulation, 115, 2262, 10.1161/CIRCULATIONAHA.106.679084
Pignatelli, 2010, Atorvastatin inhibits gp91phox circulating levels in patients with hypercholesterolemia, Arterioscler. Thromb. Vasc. Biol., 30, 360, 10.1161/ATVBAHA.109.198622
Violi, 2015, Clinical application of NOX activity and other oxidative biomarkers in cardiovascular disease: a critical review, Antioxid. Redox Signal., 23, 514, 10.1089/ars.2013.5790
Niccoli, 2013, Patients with microvascular obstruction after primary percutaneous coronary intervention show a gp91phox (NOX2) mediated persistent oxidative stress after reperfusion, Eur Heart J Acute Cardiovasc. Care, 2, 379, 10.1177/2048872613504698
Loffredo, 2012, Obesity and hypercholesterolemia are associated with NOX2 generated oxidative stress and arterial dysfunction, J. Pediatr., 161, 1004, 10.1016/j.jpeds.2012.05.042
Angelico, 2012, Weight loss is associated with improved endothelial dysfunction via NOX2-generated oxidative stress down-regulation in patients with the metabolic syndrome, Intern. Emerg. Med., 7, 219, 10.1007/s11739-011-0591-x
Olza, 2015, Continuous metabolic syndrome score is associated with specific biomarkers of inflammation and CVD risk in prepubertal children, Ann. Nutr. Metab., 66, 72, 10.1159/000369981
Derosa, 2012, Evaluation of emerging biomarkers in cardiovascular risk stratification of hypertensive patients: a 2-year study, Curr. Med. Res. Opin., 28, 1435, 10.1185/03007995.2012.717527
Tretjakovs, 2012, Circulating adhesion molecules, matrix metalloproteinase-9, plasminogen activator inhibitor-1, and myeloperoxidase in coronary artery disease patients with stable and unstable angina, Clin. Chim. Acta, 413, 25, 10.1016/j.cca.2011.10.009
Olza, 2012, Myeloperoxidase is an early biomarker of inflammation and cardiovascular risk in prepubertal obese children, Diabetes Care, 35, 2373, 10.2337/dc12-0614
Kataoka, 2014, Myeloperoxidase levels predict accelerated progression of coronary atherosclerosis in diabetic patients: insights from intravascular ultrasound, Atherosclerosis, 232, 377, 10.1016/j.atherosclerosis.2013.11.075
Sautin, 2008, Uric acid: the oxidant–antioxidant paradox, Nucleosides Nucleotides Nucleic Acids, 27, 608, 10.1080/15257770802138558
Fang, 2000, Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971–1992. National Health and Nutrition Examination Survey, JAMA, 283, 2404, 10.1001/jama.283.18.2404
Berezin, 2014, Serum uric acid predicts declining of circulating proangiogenic mononuclear progenitor cells in chronic heart failure patients, J. Cardiovasc. Thorac. Res., 6, 153, 10.15171/jcvtr.2014.004
Carr, 2000, Potential antiatherogenic mechanisms of ascorbate (vitamin C) and alpha-tocopherol (vitamin E), Circ. Res., 87, 349, 10.1161/01.RES.87.5.349
Nishi, 2010, Vitamin C prevents DNA damage induced by renovascular hypertension in multiple organs of Wistar rats, Hum. Exp. Toxicol., 29, 593, 10.1177/0960327109358267
Botelho-Ono, 2011, Acute superoxide scavenging restores depressed baroreflex sensitivity in renovascular hypertensive rats, Auton. Neurosci., 159, 38, 10.1016/j.autneu.2010.07.025
Bruno, 2012, Effect of acute administration of vitamin C on muscle sympathetic activity, cardiac sympathovagal balance, and baroreflex sensitivity in hypertensive patients, Am. J. Clin. Nutr., 96, 302, 10.3945/ajcn.112.035022
Chelazzi, 2011, Postoperative atrial fibrillation, ISRN Cardiol., 203179
May, 2013, Role of vitamin C in the function of the vascular endothelium, Antioxid. Redox Signal., 19, 2068, 10.1089/ars.2013.5205
Ashor, 2015, Effect of vitamin C and vitamin E supplementation on endothelial function: a systematic review and meta-analysis of randomised controlled trials, Br. J. Nutr., 113, 1182, 10.1017/S0007114515000227
Montero, 2014, Effect of antioxidant vitamin supplementation on endothelial function in type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials, Obes. Rev., 15, 107, 10.1111/obr.12114
Traber, 2014, Vitamin E inadequacy in humans: causes and consequences, Adv. Nutr., 5, 503, 10.3945/an.114.006254
Bozaykut, 2014, Effects of vitamin E on peroxisome proliferator-activated receptor γ and nuclear factor-erythroid 2-related factor 2 in hypercholesterolemia-induced atherosclerosis, Free Radic. Biol. Med., 70, 174, 10.1016/j.freeradbiomed.2014.02.017
Gupta, 2011, Vitamin E supplementation may ameliorate oxidative stress in type 1 diabetes mellitus patients, Clin. Lab., 57, 379
Sesso, 2008, Vitamins E and C in the prevention of cardiovascular disease in men: the physicians' health study II randomized trial, JAMA, 300, 2123, 10.1001/jama.2008.600
Myung, 2013, Efficacy of vitamin and antioxidant supplements in prevention of cardiovascular disease: systematic review and meta-analysis of randomised controlled trials, BMJ, 346, f10, 10.1136/bmj.f10
Upston, 1999, Tocopherol-mediated peroxidation of lipoproteins: implications for vitamin E as a potential antiatherogenic supplement, FASEB J., 13, 977, 10.1096/fasebj.13.9.977
Niki, 2014, Role of vitamin E as a lipid-soluble peroxyl radical scavenger: in vitro and in vivo evidence, Free Radic. Biol. Med., 66, 3, 10.1016/j.freeradbiomed.2013.03.022
Aggarwal, 2010, Tocotrienols, the vitamin E of the 21st century: its potential against cancer and other chronic diseases, Biochem. Pharmacol., 80, 1613, 10.1016/j.bcp.2010.07.043
Ali, 2015, Tocotrienol rich palm oil extract is more effective than pure tocotrienols at improving endothelium-dependent relaxation in the presence of oxidative stress, Oxidative Med. Cell. Longev., 150829
Mueller, 2005, ATVB in focus: redox mechanisms in blood vessels, Arterioscler. Thromb. Vasc. Biol., 25, 274, 10.1161/01.ATV.0000149143.04821.eb
Blankenberg, 2003, Glutathione peroxidase 1 activity and cardiovascular events in patients with coronary artery disease, N. Engl. J. Med., 349, 1605, 10.1056/NEJMoa030535
Aviram, 1998, Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase, J. Clin. Invest., 101, 1581, 10.1172/JCI1649
Meagher, 2000, Indices of lipid peroxidation in vivo: strenghts and limitations, Free Radic. Biol. Med., 28, 1745, 10.1016/S0891-5849(00)00232-X
Pirinccioglu, 2010, Malondialdehyde (MDA) and protein carbonyl (PCO) levels as biomarkers of oxidative stress in subjects with familial hypercholesterolemia, Clin. Biochem., 43, 1220, 10.1016/j.clinbiochem.2010.07.022
Viigimaa, 2010, Malondialdehyde-modified low-density lipoproteins as biomarker for atherosclerosis, Blood Press., 19, 164, 10.3109/08037051.2010.484158
Santilli, 2009, Soluble forms of RAGE in human diseases: clinical and therapeutical implications, Curr. Med. Chem., 16, 940, 10.2174/092986709787581888
Santilli, 2012, Platelet activation in obesity and metabolic syndrome, Obes. Rev., 13, 27, 10.1111/j.1467-789X.2011.00930.x
Santilli, 2015, Decreased plasma endogenous soluble RAGE, and enhanced adipokine secretion, oxidative stress and platelet/coagulative activation identify non-alcoholic fatty liver disease among patients with Familial Combined Hyperlipidemia and/or Metabolic syndrome, Vasc Pharm, 10.1016/j.vph.2015.04.004
Tesarova, 2015, RAGE and its ligands in cancer — culprits, biomarkers, or therapeutic targets?, Neoplasma, 62, 353, 10.4149/neo_2015_061
Santilli, 2007, Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins, Free Radic. Biol. Med., 43, 1255, 10.1016/j.freeradbiomed.2007.06.017
Vazzana, 2012, Endogenous secretory RAGE in obese women: association with platelet activation and oxidative stress, J. Clin. Endocrinol. Metab., 97, 1726, 10.1210/jc.2012-1473
Santilli, 2013, Effects of high-amount-high-intensity exercise on in vivo platelet activation: modulation by lipid peroxidation and AGE/RAGE axis, Thromb. Haemost., 110, 1232, 10.1160/TH13-04-0295
Hanssen, 2014, Higher levels of advanced glycation endproducts in human carotid atherosclerotic plaques are associated with a rupture-prone phenotype, Eur. Heart J., 35, 1137, 10.1093/eurheartj/eht402
Davì, 2005, Oxidant stress, inflammation and atherogenesis, Lupus, 14, 760, 10.1191/0961203305lu2216oa
Davì, 2004, Determinants of F2-isoprostane biosynthesis and inhibition in man, Chem. Phys. Lipids, 128, 149, 10.1016/j.chemphyslip.2003.10.001
Davies, 2011, F-2 isoprostanes as an indicator and risk factor for coronary heart disease, Free Radic. Biol. Med., 50, 559, 10.1016/j.freeradbiomed.2010.11.023
Roberts, 2000, Measurement of F2-isoprostanes as an index of oxidative stress in vivo, Free Radic. Biol. Med., 28, 505, 10.1016/S0891-5849(99)00264-6
Davì, 1999, In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation, Circulation, 99, 224, 10.1161/01.CIR.99.2.224
Davì, 2003, Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: role of interleukin-6 and disease duration, Circulation, 107, 3199, 10.1161/01.CIR.0000074205.17807.D0
Patrignani, 2000, Effects of vitamin E supplementation on F(2)-isoprostane and thromboxane biosynthesis in healthy cigarette smokers, Circulation, 102, 539, 10.1161/01.CIR.102.5.539
Liani, 2012, Plasma levels of soluble CD36, platelet activation, inflammation, and oxidative stress are increased in type 2 diabetic patients, Free Radic. Biol. Med., 52, 1318, 10.1016/j.freeradbiomed.2012.02.012
Puccetti, 2011, Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia, Atherosclerosis, 214, 122, 10.1016/j.atherosclerosis.2010.10.006
Dragani, 2012, Oxidative stress and platelet activation in subjects with moderate hyperhomocysteinaemia due to MTHFR 677 C→T polymorphism, Thromb. Haemost., 108, 533, 10.1160/TH11-12-0899
Patrono, 2005, Isoprostane formation and inhibition in atherothrombosis, Curr. Opin. Pharmacol., 5, 198, 10.1016/j.coph.2004.11.003
Guagnano, 2009, Determinants of platelet activation in hypertensives with microalbuminuria, Free Radic. Biol. Med., 46, 922, 10.1016/j.freeradbiomed.2009.01.005
Keaney, 2003, Framingham Study. Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study, Arterioscler. Thromb. Vasc. Biol., 23, 434, 10.1161/01.ATV.0000058402.34138.11
Pou, 2007, Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study, Circulation, 116, 1234, 10.1161/CIRCULATIONAHA.107.710509
Santilli, 2006, Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus, J. Am. Coll. Cardiol., 47, 391, 10.1016/j.jacc.2005.03.079
Davì, 2002, Platelet activation in obese women: role of inflammation and oxidant stress, JAMA, 288, 2008, 10.1001/jama.288.16.2008
Vazzana, 2011, Determinants of increased cardiovascular disease in obesity and metabolic syndrome, Curr. Med. Chem., 18, 5267, 10.2174/092986711798184299
Meyer, 2013, Dietary patterns are associated with plasma F₂-isoprostanes in an observational cohort study of adults, Free Radic. Biol. Med., 57, 201, 10.1016/j.freeradbiomed.2012.08.574
Davì, 1997, Diabetes mellitus, hypercholesterolemia, and hypertension but not vascular disease per se are associated with persistent platelet activation in vivo. Evidence derived from the study of peripheral arterial disease, Circulation, 96, 69, 10.1161/01.CIR.96.1.69
Davì, 1982, Thromboxane B2 formation and platelet sensitivity to prostacyclin in insulin-dependent and insulin-independent diabetics, Thromb. Res., 26, 359, 10.1016/0049-3848(82)90254-7
LeLeiko, 2009, Usefulness of elevations in serum choline and free F2-isoprostane to predict 30-day cardiovascular outcomes in patients with acute coronary syndrome, Am. J. Cardiol., 104, 638, 10.1016/j.amjcard.2009.04.047
Roest, 2008, High levels of urinary F2-isoprostanes predict cardiovascular mortality in postmenopausal women, J. Clin. Lipidol., 2, 298, 10.1016/j.jacl.2008.06.004
Pignatelli, 2015, Serum NOX2 and urinary isoprostanes predict vascular events in patients with atrial fibrillation, Thromb. Haemost., 113, 617, 10.1160/TH14-07-0571
Patrono, 1997, Isoprostane: potential markers of oxidant stress in atherothrombotic disease, Arterioscler. Thromb. Vasc. Biol., 17, 2309, 10.1161/01.ATV.17.11.2309
Kuo, 2014, Lin CL. Cerebrospinal fluid biomarkers for neuropsychological symptoms in early stage of late-onset Alzheimer's disease, Int J Neurosci
Asombang, 2013, Gastric cancer in Zambian adults: a prospective case-control study that assessed dietary intake and antioxidant status by using urinary isoprostane excretion, Am. J. Clin. Nutr., 97, 1029, 10.3945/ajcn.112.051284
Kong, 2014, Oxidative balance score, colorectal adenoma, and markers of oxidative stress and inflammation, Cancer Epidemiol. Biomark. Prev., 23, 545, 10.1158/1055-9965.EPI-13-0619
Santilli, 2011, TP receptor activation and inhibition in atherothrombosis: the paradigm of diabetes mellitus, Intern. Emerg. Med., 6, 203, 10.1007/s11739-010-0440-3
Undas, 2012, Simvastatin administration reduces thromboxane production in subjects taking aspirin: links between aspirin resistance and thrombin generation, Int. J. Cardiol., 154, 59, 10.1016/j.ijcard.2010.09.093
Santilli, 2010, Thromboxane and prostacyclin biosynthesis in heart failure of ischemic origin: effects of disease severity and aspirin treatment, J. Thromb. Haemost., 8, 914, 10.1111/j.1538-7836.2010.03820.x
Davì, 2007, Platelet activation and atherothrombosis, N. Engl. J. Med., 357, 2482, 10.1056/NEJMra071014
Bauer, 2014, Pathophysiology of isoprostanes in the cardiovascular system: implications of isoprostane-mediated thromboxane A2 receptor activation, Br. J. Pharmacol., 171, 3115, 10.1111/bph.12677
Santilli, 2015, Oxidative stress-related mechanisms affecting response to aspirin in diabetes mellitus, Free Radic. Biol. Med., 80, 101, 10.1016/j.freeradbiomed.2014.12.010
Schwedhelm, 2010, Redox-generated isoprostanes are associated with residual platelet activity in aspirin treated patients with stable coronary heart disease, J. Thromb. Haemost., 8, 2662, 10.1111/j.1538-7836.2010.04117.x
Kranzhofer, 2006, Aspirin resistance in coronary artery disease is correlated to elevated markers for oxidative stress but not to the expression of cyclooxygenase (COX)1/2, a novel COX-1 polymorphism or the PlA(1/2) polymorphism, Platelets, 17, 163, 10.1080/09537100500441101
Ames, 2012, Aspirinin sensitive thromboxane generation is associated with oxidative stress in type 2 diabetes mellitus, Thromb. Res., 30, 350, 10.1016/j.thromres.2012.03.025
Santilli, 2014, Circulating myeloid-related protein-8/14 is related to thromboxane-dependent platelet activation in patients with acute coronary syndrome, with and without ongoing low-dose aspirin treatment, J. Am. Heart Assoc., 3, 10.1161/JAHA.114.000903
Pastori, 2015, Nox-2 up-regulation and platelet activation: novel insights, Prostaglandins Other Lipid Mediat., 10.1016/j.prostaglandins.2015.03.010
Cangemi, 2012, Platelet isoprostane overproduction in diabetic patients treated with aspirin, Diabetes, 61, 1626, 10.2337/db11-1243
Carnevale, 2012, Dark chocolate inhibits platelet isoprostanes via NOX2 down-regulation in smokers, J. Thromb. Haemost., 10, 125, 10.1111/j.1538-7836.2011.04558.x
Nickenig, 1999, Statin-sensitive dysregulated AT1 receptor function and density in hypercholesterolemic men, Circulation, 100, 2131, 10.1161/01.CIR.100.21.2131
Stepp, 2002, Native LDL and minimally oxidized LDL differentially regulate superoxide anion in vascular endothelium in situ, Am. J. Physiol. Heart Circ. Physiol., 283, H750, 10.1152/ajpheart.00029.2002
Bergt, 2004, The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport, Proc. Natl. Acad. Sci., 101, 13032, 10.1073/pnas.0405292101
Khera, 2011, Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis, N. Engl. J. Med., 364, 127, 10.1056/NEJMoa1001689
Ferroni, 2006, Endothelial dysfunction and oxidative stress in arterial hypertension, Nutr. Metab. Cardiovasc. Dis., 16, 222, 10.1016/j.numecd.2005.11.012
Landmesser, 2003, Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension, J. Clin. Invest., 111, 1201, 10.1172/JCI200314172
White, 1994, Superoxide and peroxynitrite in atherosclerosis, Proc. Natl. Acad. Sci. U. S. A., 91, 1044, 10.1073/pnas.91.3.1044
Korbecki, 2013, The effect of reactive oxygen species on the synthesis of prostanoids from arachidonic acid, J. Physiol. Pharmacol., 64, 409
Touyz, 2004, Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance?, Hypertension, 44, 248, 10.1161/01.HYP.0000138070.47616.9d
Epstein, 2009, Recent changes in the landscape of combination RAS blockade, Expert. Rev. Cardiovasc. Ther., 7, 1373, 10.1586/erc.09.127
Touyz, 2004, Reactive oxygen species and angiotensin II signaling in vascular cells – implications in cardiovascular disease, Braz. J. Med. Biol. Res., 37, 1263, 10.1590/S0100-879X2004000800018
Touyz, 2000, Signal transduction mechanisms mediating the physiological and patho-physiological actions of angiotensin II in vascular smooth muscle cells, Pharmacol. Rev., 52, 639
Klatsky, 1986, The relationships between alcoholic beverage use and other trials to blood pressure: a new Kaiser Permanente study, Circulation, 73, 628, 10.1161/01.CIR.73.4.628
Lian, 1915, L'alcolisme cause d'hipertension arterielle, Bull. Acad. Natl Med., 74, 525
Marchi, 2014, Hypertension and chronic ethanol consumption: what do we know after a century of study?, World J. Cardiol., 6, 283, 10.4330/wjc.v6.i5.283
Toda, 2010, Vascular actions of nitric oxide as affected by exposure to alcohol, Alcohol, 45, 347, 10.1093/alcalc/agq028
Ceron, 2014, Vascular oxidative stress: a key factor in the development of hypertension associated with ethanol consumption, Curr. Hypertens. Rev., 10, 213, 10.2174/157340211004150319122736
Shirpoor, 2013, Ethanol promotes rat aortic vascular smooth muscle cell proliferation via increase of homocysteine and oxidized-low-density lipoprotein, J. Cardiol., 62, 374, 10.1016/j.jjcc.2013.06.003
Gonzaga, 2015, Ethanol withdrawal increases oxidative stress and reduces nitric oxide bioavailability in the vasculature of rats, Alcohol, 49, 47, 10.1016/j.alcohol.2014.12.001
Husain, 2011, Chronic ethanol ingestion induces aortic inflammation/oxidative endothelial injury and hypertension in rats, Hum. Exp. Toxicol., 30, 930, 10.1177/0960327110384520
Tirapelli, 2008, Ethanol consumption increases blood pressure and alters the responsiveness of the mesenteric vasculature in rats, J. Pharm. Pharmacol., 60, 331, 10.1211/jpp.60.3.0008
Crestani, 2014, Cardiovascular alterations at different stages of hypertension development during ethanol consumption: time-course of vascular and autonomic changes, Toxicol. Appl. Pharmacol., 280, 245, 10.1016/j.taap.2014.08.012
Husain, 2008, Chronic alcohol-induced oxidative endothelial injury relates to angiotensin II levels in the rat, Mol. Cell. Biochem., 307, 51, 10.1007/s11010-007-9583-6
Baptista Rde, 2014, Endothelial AT₁ and AT₂ pathways in aortic responses to angiotensin II after stress and ethanol consumption in rats, Stress, 17, 512, 10.3109/10253890.2014.966262
Aouacheri, 2015, The investigation of the oxidative stress-related parameters in type 2 diabetes mellitus, Can. J. Diabetes, 39, 44, 10.1016/j.jcjd.2014.03.002
Paneni, 2015, Role of oxidative stress in endothelial insulin resistance, World J. Diabetes, 6, 326, 10.4239/wjd.v6.i2.326
Belia, 2009, Oxidative-induced membrane damage in diabetes lymphocytes: effects on intracellular Ca(2+) homeostasis, Free Radic. Res., 43, 138, 10.1080/10715760802629588
Funk, 2012, Orr AW Hyperglycemia and endothelial dysfunction in atherosclerosis: lessons from type 1 diabetes, Int. J. Vasc. Med., 569654
Falcone, 2005, Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men, Arterioscler. Thromb. Vasc. Biol., 25, 1032, 10.1161/01.ATV.0000160342.20342.00
Cosentino, 2003, High glucose causes upregulation of cyclooxygenase-2 and alters prostanoid profile in human endothelial cells: role of protein kinase C and reactive oxygen species, Circulation, 107, 1017, 10.1161/01.CIR.0000051367.92927.07
Du, 2006, Insulin resistance reduces arterial prostacyclin synthase and eNOS activities by increasing endothelial fatty acid oxidation, J. Clin. Invest., 116, 1071, 10.1172/JCI23354
Pagnin, 2005, Diabetes induces p66shc gene expression in human peripheral blood mononuclear cells: relationship to oxidative stress, J. Clin. Endocrinol. Metab., 90, 1130, 10.1210/jc.2004-1283
Paneni, 2012, p66 Shc as the engine of vascular aging, Curr. Vasc. Pharmacol., 10, 697, 10.2174/157016112803520747
Camici, 2007, Genetic deletion of p66(Shc) adaptor protein prevents hyperglycemia-induced endothelial dysfunction and oxidative stress, Proc. Natl. Acad. Sci., 104, 5217, 10.1073/pnas.0609656104
Chen, 2013, Cross-talk between SIRT1 and p66Shc in vascular diseases, Trends Cardiovasc. Med., 23, 237, 10.1016/j.tcm.2013.01.001
Tousoulis, 2013, Diabetes mellitus-associated vascular impairment: novel circulating biomarkers and therapeutic approaches, J. Am. Coll. Cardiol., 62, 667, 10.1016/j.jacc.2013.03.089
Spranger, 2003, Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study, Diabetes, 52, 812, 10.2337/diabetes.52.3.812
O'Connell, 2015, DNA Methylation and MicroRNA-Based Biomarkers for Risk of Type 2 Diabetes, Curr. Diabetes Rev.
Yara, 2015, Oxidative stress and DNA methylation regulation in the metabolic syndrome, Epigenomics, 7, 283, 10.2217/epi.14.84
Chambers, 2015, Epigenome-wide association of DNA methylation markers in peripheral blood from Indian Asians and Europeans with incident type 2 diabetes: a nested case-control study, Lancet Diabet. Endocrinol., 3, 526, 10.1016/S2213-8587(15)00127-8
Gillberg, 2015, The potential use of DNA methylation biomarkers to identify risk and progression of type 2 diabetes, Front. Endocrinol., 6, 43, 10.3389/fendo.2015.00043
Nilsson, 2014, Altered DNA methylation and differential expression of genes influencing metabolism and inflammation in adipose tissue from subjects with type 2 diabetes, Diabetes, 63, 2962, 10.2337/db13-1459
Zampetaki, 2010, Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes, Circ. Res., 107, 810, 10.1161/CIRCRESAHA.110.226357
Shantsila, 2010, Circulating microparticles in cardiovascular disease: implications for atherogenesis and atherothrombosis, J. Thromb. Haemost., 8, 2358, 10.1111/j.1538-7836.2010.04007.x
Tsimerman, 2011, Involvement of microparticles in diabetic vascular complications, Thromb. Haemost., 106, 310, 10.1160/TH10-11-0712
Chen, 2012, Plasma endothelial microparticles and their correlation with the presence of hypertension and arterial stiffness in patients with type 2 diabetes, J. Clin. Hypertens. (Greenwich), 14, 455, 10.1111/j.1751-7176.2012.00631.x
Bernard, 2009, Increased levels of endothelial microparticles CD144 (VE-Cadherin) positives in type 2 diabetic patients with coronary noncalcified plaques evaluated by multidetector computed tomography (MDCT), Atherosclerosis, 203, 429, 10.1016/j.atherosclerosis.2008.07.039
May, 2013, Role of vitamin C in the function of the vascular endothelium, Antioxid. Redox Signal., 19, 2068, 10.1089/ars.2013.5205
Bozaykut, 2014, Effects of vitamin E on peroxisome proliferator-activated receptor and nuclear factor-erythroid related factor 2 in hypercholesterolemia-induced atherosclerosis, Free Radic. Biol. Med., 70, 174, 10.1016/j.freeradbiomed.2014.02.017
Chiarelli, 2004, Effects of vitamin E supplementation on intracellular antioxidant enzyme production in adolescents with type 1 diabetes and early microangiopathy, Pediatr. Res., 56, 720, 10.1203/01.PDR.0000141990.12375.13
Siti, 2015, The role of oxidative stress, antioxidants and vascular inflammation in cardiovascular disease (a review), Vasc. Pharmacol., 10.1016/j.vph.2015.03.005
Kris-Etherton, 2004, Nutrition Committee of the American Heart Association Council on Nutrition, Physical Activity, and Metabolism. Antioxidant vitamin supplements and cardiovascular disease, Circulation, 110, 637, 10.1161/01.CIR.0000137822.39831.F1
Buijsse, 2008, Both a- and b carotene, but not tocopherols and vitamin C, are inversely related to 15-year cardiovascular mortality in Dutch elderly men, J. Nutr., 138, 344, 10.1093/jn/138.2.344
Mahajan, 2007, Antihypertensive and antioxidant action of amlodipine and vitamin C in patients of essential hypertension, J. Clin. Biochem. Nutr., 40, 141, 10.3164/jcbn.40.141
Rodrigo, 2008, Decrease in oxidative stress through supplementation of vitamins C and E is associated with a reduction in blood pressure in patients with essential hypertension, Clin. Sci., 114, 625, 10.1042/CS20070343
Vivekananthan, 2003, Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomized trials, Lancet, 361, 2017, 10.1016/S0140-6736(03)13637-9
Eidelman, 2004, Randomized trials of vitamin E in the treatment and prevention of cardiovascular disease, Arch. Intern. Med., 164, 1552, 10.1001/archinte.164.14.1552
Cook, 2007, A randomized factorial trial of vitamins C, E, and beta-carotene in the secondary prevention of cardiovascular events in women: results from the women's antioxidant cardiovascular study (WACS), Arch. Intern. Med., 167, 1610, 10.1001/archinte.167.15.1610
Miller, 2005, Meta-analysis: High-dosage vitamin E supplementation may increase all-cause mortality, Ann. Intern. Med., 142, 37, 10.7326/0003-4819-142-1-200501040-00110
Bjelakovic, 2007, Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis, JAMA, 297, 842, 10.1001/jama.297.8.842
Montezano, 2014, Reactive oxygen species, vascular Noxs, and hypertension: focus on translational and clinical research, Antioxid. Redox Signal., 20, 164, 10.1089/ars.2013.5302
Sanyal, 2010, Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis, N. Engl. J. Med., 362, 1675, 10.1056/NEJMoa0907929
Meagher, 2001, Effects of vitamin E on lipid peroxidation in healthy persons, JAMA, 285, 1178, 10.1001/jama.285.9.1178
Block, 2008, The effect of vitamins C and E on biomarkers of oxidative stress depends on baseline level, Free Radic. Biol. Med., 45, 377, 10.1016/j.freeradbiomed.2008.04.005
Roberts, 2007, The relationship between dose of vitamin E and suppression of oxidative stress in humans, Free Radic. Biol. Med., 43, 1388, 10.1016/j.freeradbiomed.2007.06.019
Davì, 2010, Nutraceuticals in diabetes and metabolic syndrome, Cardiovasc. Ther., 28, 216, 10.1111/j.1755-5922.2010.00179.x
Hansen, 2005, Effect of red wine and red grape extract on blood lipids, haemostatic factors, and other risk factors for cardiovascular disease, Eur. J. Clin. Nutr., 59, 449, 10.1038/sj.ejcn.1602107
Lippi, 2010, Moderate red wine consumption and cardiovascular disease risk: beyond the “French paradox”, Semin. Thromb. Hemost., 36, 59, 10.1055/s-0030-1248725
Gresele, 2011, Effects of resveratrol and other wine polyphenols on vascular function: an update, J. Nutr. Biochem., 22, 201, 10.1016/j.jnutbio.2010.07.004
Scoditti, 2012, Mediterranean diet polyphenols reduce inflammatory angiogenesis through MMP-9 and COX-2 inhibition in human vascular endothelial cells: a potentially protective mechanism in atherosclerotic vascular disease and cancer, Arch. Biochem. Biophys., 527, 81, 10.1016/j.abb.2012.05.003
Botden, 2012, Red wine extract protects against oxidative-stress-induced endothelial senescence, Clin. Sci., 123, 499, 10.1042/CS20110679
Schrieks, 2013, Effect of red wine consumption on biomarkers of oxidative stress, Alcohol Alcohol., 48, 153, 10.1093/alcalc/ags086
Daiber, 2010, Characterization of the antioxidant properties of pentaerithrityl tetranitrate (PETN)-induction of the intrinsic antioxidative system heme oxygenase-1 (HO-1), Methods Mol. Biol., 594, 311, 10.1007/978-1-60761-411-1_22
Munzel, 2009, Nebivolol: the somewhat-different betaadrenergic receptor blocker, J. Am. Coll. Cardiol., 54, 1491, 10.1016/j.jacc.2009.05.066
Fratta Pasini, 2005, Nebivolol decreases oxidative stress in essential hypertensive patients and increases nitric oxide by reducing its oxidative inactivation, J. Hypertens., 23, 589, 10.1097/01.hjh.0000160216.86597.ff
Violi, 2014, Antioxidant and antiplatelet effects of atorvastatin by Nox2 inhibition, Trends Cardiovasc. Med., 24, 142, 10.1016/j.tcm.2013.09.006
Bonnefont-Rousselot, 2003, An intracellular modulation of free radical production could contribute to the beneficial effects of metformin towards oxidative stress, Metabolism, 52, 586, 10.1053/meta.2003.50093
Formoso, 2008, Decreased in vivo oxidative stress and decreased platelet activation following metformin treatment in newly diagnosed type 2 diabetic subjects, Diabetes Metab. Res. Rev., 24, 231, 10.1002/dmrr.794
Ferrannini, 2014, The target of metformin in type 2 diabetes, N. Engl. J. Med., 371, 1547, 10.1056/NEJMcibr1409796
Randriamboavonjy, 2015, Metformin reduces hyper-reactivity of platelets from patients with polycystic ovary syndrome by improving mitochondrial integrity, Thromb. Haemost., 114
Vázquez-Medina, 2013, Angiotensin receptor-mediated oxidative stress is associated with impaired cardiac redox signaling and mitochondrial function in insulin-resistant rats, Am. J. Physiol. Heart Circ. Physiol., 305, H599, 10.1152/ajpheart.00101.2013
Chiarelli, 2005, Effects of irbesartan on intracellular antioxidant enzyme expression and activity in adolescents and young adults with early diabetic angiopathy, Diabetes Care, 28, 1690, 10.2337/diacare.28.7.1690
Drummond, 2011, Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets, Nat. Rev. Drug Discov., 10, 453, 10.1038/nrd3403
ten Freyhaus, 2006, Novel Nox inhibitor VAS2870 attenuates PDGF-dependent smooth muscle cell chemotaxis, but not proliferation, Cardiovasc. Res., 71, 331, 10.1016/j.cardiores.2006.01.022
Laleu, 2010, First in class, potent, and orally bioavailable NADPH oxidase isoform 4 (Nox4) inhibitors for the treatment of idiopathic pulmonary fibrosis, J. Med. Chem., 53, 7715, 10.1021/jm100773e
Gianni, 2010, A novel and specific NADPH oxidase-1 (Nox1) small-molecule inhibitor blocks the formation of functional invadopodia in human colon cancer cells, ACS Chem. Biol., 5, 981, 10.1021/cb100219n
Stachowicz, 2014, Mitochondrial aldehyde dehydrogenase activation by Alda-1 inhibits atherosclerosis and attenuates hepatic steatosis in apolipoprotein E-knockout mice, J. Am. Heart Assoc., 3, 10.1161/JAHA.114.001329
Fu, 2014, Alda‐1 reduces cerebral ischemia/reperfusion injury in rat through clearance of reactive aldehydes, Naunyn Schmiedeberg's Arch. Pharmacol., 387, 87, 10.1007/s00210-013-0922-8
Dare, 2015, Protection against renal ischemia–reperfusion injury in vivo by the mitochondria targeted antioxidant MitoQ, Redox Biology, 5, 163, 10.1016/j.redox.2015.04.008
Harris, 2008, MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1, Proc. Natl. Acad. Sci. U. S. A., 105, 1516, 10.1073/pnas.0707493105
Asgeirsdóttir, 2012, MicroRNA-126 contributes to renal microvascular heterogeneity of VCAM-1 protein expression in acute inflammation, Am. J. Physiol. Ren. Physiol., 302, F1630, 10.1152/ajprenal.00400.2011
van Solingen, 2011, MicroRNA-126 modulates endothelial SDF-1 expression and mobilization of Sca-1(+)/Lin(−) progenitor cells in ischaemia, Cardiovasc. Res., 92, 449, 10.1093/cvr/cvr227
Wang, 2008, The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis, Dev. Cell, 15, 261, 10.1016/j.devcel.2008.07.002
Mondadori Dos Santos, 2015, MiR-126 is involved in vascular remodeling under laminar shear stress, Biomed. Res. Int., 2015, 497280, 10.1155/2015/497280
Zampetaki, 2013, Oxidative stress in atherosclerosis: the role of microRNAs in arterial remodeling, Free Radic. Biol. Med., 64, 69, 10.1016/j.freeradbiomed.2013.06.025
Santilli, 2015, Oxidative stress drivers and modulators in obesity and cardiovascular disease: from biomarkers to therapeutic approach, Curr. Med. Chem., 22, 582, 10.2174/0929867322666141128163739
Sun, 2013, Endothelial microRNAs and atherosclerosis, Curr. Atheroscler. Rep., 15, 372, 10.1007/s11883-013-0372-2
Giorgio, 2015, Oxidative stress and the unfulfilled promises of antioxidant agents, E cancer med. sci., 9, 556
Gupta, 2012, Upsides and downsides of reactive oxygen species for cancer: the roles of reactive oxygen species in tumorigenesis, prevention, and therapy, Antioxid. Redox Signal., 16, 1295, 10.1089/ars.2011.4414
Hitchler, 2012, Redox regulation of the epigenetic landscape in cancer: a role for metabolic reprogramming in remodeling the epigenome, Free Radic. Biol. Med., 53, 2178, 10.1016/j.freeradbiomed.2012.09.028
Sayin, 2014, Antioxidants accelerate lung cancer progression in mice, Sci Transl Med, 6, 10.1126/scitranslmed.3007653